Health Care & Life Sciences » Pharmaceuticals | GRUPO International Inc.

GRUPO International Inc. | Balance Sheet

Fiscal year is October-September. All values USD Thousands.
2006
2007
2008
2009
2010
Cash & Short Term Investments
0.90
1.00
0.90
0.80
0.80
Other Current Assets
21.50
24.50
-
-
1.50
Total Current Assets
22.40
25.40
0.90
0.80
2.30
Net Property, Plant & Equipment
5.60
4.90
4.30
3.70
3.30
Intangible Assets
69.40
54.00
-
-
-
Total Assets
97.50
84.30
5.20
4.60
5.50
Accounts Payable
511.60
665.90
92.50
87.40
89.30
Other Current Liabilities
651.20
686.70
723.90
763.10
349.10
Total Current Liabilities
1,162.80
1,352.60
816.40
850.50
438.40
Total Liabilities
1,162.80
1,352.60
816.40
850.50
438.40
Common Equity (Total)
1,068.40
1,271.40
814.30
849.00
435.80
Total Shareholders' Equity
1,065.30
1,268.30
811.20
845.90
432.80
Total Equity
1,065.30
1,268.30
811.20
845.90
432.80
Liabilities & Shareholders' Equity
97.50
84.30
5.20
4.60
5.50
Preferred Stock (Carrying Value)
3.10
3.10
3.10
3.10
3.00

About GRUPO International

View Profile
Address
14 Laurel Boulevard
Collingwood Ontario L9Y 5A8
Canada
Employees -
Website -
Updated 07/08/2019
Grupo International, Inc. operates as a development stage company, which is engaged in development and marketing of a proposed vaccine designed to combat HIV/AIDS. The company operates through two distinct divisions: The Pharmaceutical Division and The Basic Materials Division. The Pharmaceutical division will continually look for medical cures.